Zugriffe | |
---|---|
Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU | 52 |
November 2023 | Dezember 2023 | Januar 2024 | Februar 2024 | März 2024 | April 2024 | Mai 2024 | |
---|---|---|---|---|---|---|---|
Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU | 6 | 1 | 1 | 7 | 0 | 1 | 0 |
Zugriffe | |
---|---|
2019_Ertaş_etal.pdf | 113 |
2019_Ertaş_etal.pdf | 6 |